166 filings
Page 8 of 9
6-K
texeap9a
13 May 15
Galmed Pharmaceuticals Reports First Quarter 2015 Financial Results and Provides Business Update
12:00am
6-K
qp6 3lcv9p
2 Apr 15
Current report (foreign)
12:00am
6-K
c0ke3sp3 4lh09mv
31 Mar 15
Galmed Pharmaceuticals Reports Full Year 2014 Financial Results and Provides Business Update
12:00am
6-K
zv0qc6xgjmowl
9 Mar 15
Current report (foreign)
12:00am
6-K
gg4n8
28 Jan 15
Galmed and Perrigo Execute Manufacturing Agreement for Large-Scale Aramchol API Production
12:00am
6-K
qzohfea8 pw
5 Jan 15
Galmed Pharmaceuticals Announces the Appointment of
12:00am
6-K
2j2k 3162
15 Dec 14
Current report (foreign)
12:00am
6-K
jfau564cyofmmocx7
1 Dec 14
Galmed Pharmaceuticals Completes Analysis of a Pharmacokinetic Study of Aramchol in Healthy Volunteers
12:00am
6-K
lqd0n1rz
13 Nov 14
Galmed Pharmaceuticals Announces First Administration of Aramchol in its Phase IIa Trial for the Treatment of Cholesterol Gallstones
12:00am
6-K
wpvvs0d9
12 Nov 14
Galmed Pharmaceuticals Provides Business Update
12:00am
6-K
qxfkxk
6 Nov 14
Current report (foreign)
12:00am
6-K
cjzvnyg
7 Oct 14
Current report (foreign)
12:00am
6-K
xtu rm9kmy
29 Sep 14
Current report (foreign)
12:00am
6-K
fcz82m3j2nb yu
23 Sep 14
GalmedPharmaceuticalsAnnounces U.S. FDA Approval of Fast Track Designation of Aramchol for the Treatment of NASH
12:00am
6-K
nvt0y8fwrsimgk
2 Sep 14
Galmed Pharmaceuticals Completes Two Chronic Toxicology Studies and Reports No Significant Adverse Events
12:00am
6-K
7fbqw
25 Jul 14
Galmed Pharmaceuticals Reports First Half 2014 Financial Results
12:00am
6-K
iqqaek v8o0f
22 Jul 14
Galmed Announces FDA Clearance of IND of Aramchol
12:00am
6-K
omlv8lf
16 Jun 14
Current report (foreign)
12:00am
6-K
s8juvz7xb2phwic3
9 Jun 14
Galmed Pharmaceuticals Announces the Filing of a Provisional Patent Application for the Use of Aramchol for the Treatment of Lipodystrophy
12:00am
6-K
z4e9g6
4 Jun 14
Recently Published Independent Research Supports the Importance of Reverse Cholesterol Transport on NASH Pathogenesis
12:00am